BAG3V468M impairs proteasomal protein clearance and induces dilated cardiomyopathy in vivo

Federica Diofano1, Ionela Emilia Giorgiana Madac1, Dennis Koeble1

  • 1Molecular Cardiology, Department of Internal Medicine II, University of Ulm, Ulm, Germany.

Insights

Genetic variants in BAG3 protein can cause dilated cardiomyopathy (DCM). This study shows a specific BAG3 mutation (V468M) impairs protein quality control, leading to DCM-like heart problems in zebrafish by disrupting protein clearance.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Proteostasis Research

Background:

  • Idiopathic dilated cardiomyopathy (DCM) is a primary cause of heart failure, linked to genetic factors.
  • BAG3 gene variants are implicated in DCM, suggesting a role in protein quality control (PQC) and proteinopathy.

Purpose of the Study:

  • Investigate the in vivo molecular effects of a specific BAG3 missense variant (V468M) associated with familial DCM.
  • Determine the impact of BAG3 V468M on cardiac function, myocardial structure, and proteostasis.

Main Methods:

  • Ectopic expression of human BAG3 V468M in wild-type zebrafish embryos.
  • Phenotypic analysis including echocardiography, heart rate, and contractility measurements.
  • Transmission electron microscopy for ultrastructural analysis.
  • Assessment of autophagy and ubiquitin-proteasome system markers.

Main Results:

  • BAG3 V468M expression induced a DCM-like phenotype in zebrafish, with ventricular dilation, reduced heart rate, and impaired contractility.
  • Ultrastructural analysis revealed disrupted myocardial architecture and sarcomeric organization.
  • While autophagy markers were unchanged, ubiquitinated protein accumulation indicated impaired ubiquitin-proteasome system function.

Conclusions:

  • The BAG3 V468M variant triggers a DCM-like phenotype in vivo.
  • Disrupted myocardial architecture and altered proteostasis, specifically impaired ubiquitin-mediated protein turnover, contribute to BAG3-associated cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...